Intra-individual somatic variation of the rs669 polymorphism of the A2M gene in patients with colorectal cancer
Variación somática intraindividual del polimorfismo rs669 del gen A2M en pacientes con cáncer colorrectal
DOI:
https://doi.org/10.15446/revfacmed.v68n1.79864Palabras clave:
Somatic Variation, rs669, Colorectal cancer (en)Variación somática, rs669, Cáncer colorrectal (es)
Dear Editor:
An intra-individual somatic variation (ISV) is described as the genetic difference among different tissues of the same individual. ISV increases with age, may not manifest a defined phenotype, and is associated with neurological, hematological, and immune disorders, especially with cancer.1
To analyze possible ISV in Mexican patients with colorectal cancer (CRC), we studied the polymorphism rs669 (c.2998 A>G, p.Ile1000Val) of the A2M gene, which encodes for the alpha-2 macroglobulin protein, a protease inhibitor involved in tumor progression and proliferation.2 This variant is located near a thioester site, which is necessary for the inhibitory function of the protein.
Estimado editor:
La variación somática intraindividual (VSI) se describe como la diferencia genética entre los tejidos de un mismo individuo. La VSI se incrementa conforme avanza la edad, puede no manifestar un fenotipo definido y se asocia con alteraciones neurológicas, hematológicas e inmunes y, de manera especial, con cáncer.1
Para analizar la posible VSI en pacientes mexicanos con cáncer colorrectal (CCR), Yang et al.2 estudiaron el polimorfismo rs669 (c.2998 A>G, p.Ile1000Val) del gen A2M que codifica para la proteína alfa-2 macroglobulina, una inhibidora de proteasas involucrada en la progresión y proliferación del tumor. Esta variante se localiza cerca de un sitio tioéster, necesario para la función inhibidora de la proteína.
Descargas
Citas
Li C, Williams SM. Human Somatic Variation: It’s Not Just for Cancer Anymore. Curr Genet Med Rep. 2013;1(4):212-18. http://doi.org/dgk6.
Yang Y, Hong H, Zhang Y, and Cai W. Molecular Imaging of Proteases in Cancer. Cancer Growth Metastasis. 2009;2:13-27. http://doi.org/dgk8.
Ramírez-Plascencia HHF. Asociación del polimorfismo c.2998a>g del gen A2M con cáncer colorrectal en pacientes del occidente de México [tesis]. Las Agujas: Universidad de Guadalajara; 2015.
Gustincich S, Manfioletti G, Del Sal C, Schneider P, Carninci P. A fast method for high quality genomic DNA extraction from whole human blood. Biotechniques. 1991;11(3):298-301.
Bogaert J, Prenen J. Molecular genetics of colorectal cancer. Ann Gastroenterol. 2014;27(1):9-14.
Mitelman F, Johansson B, Mertens F, editors. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer. National Cancer Institute; 1994 [cited 2019 Apr 12]. Available from: https://bit.ly/2DVoQM2.
Acuña-Hidalgo R, Veltman JA, Hoischen A. New insights into the generation and role of de novo mutations in health and disease. Genome Biol. 2016;17(1):241. http://doi.org/f9fzdv.
O'Huallachain M, Karczewski KJ, Weissman SM, Urban AE, Snyder MP. Extensive genetic variation in somatic human tissues. Proc Natl Acad Sci USA. 2012;109(44):18018-23. http://doi.org/f4dm6j.
Sender R, Fuchs S, y Milo R. Revised estimate for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(18):e1002533. http://doi.org/f82nq2.
Rai PS, Pai GC, Alvares JF, Bellampalli R, Gopinath PM, Satyamoorthy K. Intraindividual somatic variations in MTHFR gene polymorphisms in relation to colon cancer. Pharmacogenomics. 2014;15(3):349-59. http://doi.org/f53gqp.
Marsh S, Mallon MA, Goodfellow P, McLeod HL. Concordance of pharmacogenetics markers in germline and colorectal tumor DNA. Pharmacogenomics. 2005;6(8):873-7. http://doi.org/ch6mtz.
Van Huis-Tanja L, Kweekel D, Gelderblom H, Koopman M, Punt K, Guchelaar HJ, et al. Concordance of genotype for polymorphisms in DNA isolated from peripheral blood and colorectal cancer tumor samples. Pharmacogenomics. 2013;14(16):2005-12. http://doi.org/f5hvtx.
Balboa E, Duran G, Lamas MJ, Gómez-Caamaño A, Celeiro-Muñoz C, Lopez R, et al. Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response. Pharmacogenomics. 2010;11(6):747-61. http://doi.org/d853jc.
Licencia
Derechos de autor 2020 Revista de la Facultad de Medicina

Esta obra está bajo una licencia Creative Commons Reconocimiento 3.0 Unported.
-








